NEWARK, Del., July 11, 2026 — The global Healthcare Antibody Quantification Market is expected to witness robust growth as biologics development, immunology research, and precision diagnostics continue expanding across pharmaceutical and biotechnology industries. According to Future Market Insights (FMI), the market is projected to grow from USD 7.8 billion in 2026 to USD 17.0 billion by...

According to Future Market Insights (FMI), the global breast cancer diagnostics market is poised for significant growth, driven by the increasing prevalence of breast cancer, growing awareness regarding early detection, expanding screening initiatives, and continuous advancements in diagnostic technologies. The adoption of imaging systems, genomic testing platforms, liquid biopsy technologies,...

The global Dental Disinfectants Market, according to Future Market Insights, is witnessing steady growth, driven by increasing infection prevention requirements, stricter sterilization regulations, and rising demand for advanced dental hygiene solutions across clinics and hospitals. The market is projected to grow from USD 572.3 million in 2026 to USD 784.2 million by 2036, registering a CAGR...

NEWARK, Del., USA, JUNE 15, 2026 — According to the latest analysis by Future Market Insights (FMI), the global Lung Cancer Surgery Market is expected to witness steady growth over the next decade, driven by rising early-stage lung cancer diagnosis, increasing adoption of minimally invasive surgical techniques, and growing investments in advanced thoracic surgical technologies. As...

The oncology precision medicine industry is experiencing transformative growth driven by advancements in genomic profiling and targeted therapies. This sector is redefining cancer treatment paradigms through personalized approaches, substantially enhancing patient outcomes. The evolving landscape is marked by increased investment in precision diagnostics and biomarker-driven drug development,...

The global PD-1/PD-L1 inhibitor market is poised for substantial expansion as oncology treatment pathways increasingly integrate immune checkpoint inhibitors across earlier lines of care and broader tumor categories. Valued at USD 67,996.6 million in 2026, the market is projected to reach USD 232,839.8 million by 2036, expanding at a CAGR of 13.1% during the forecast period. Growth is...

According to Future Market Insights (FMI), the global prostate cancer market is poised for significant expansion, driven by rising prostate cancer incidence, increasing adoption of precision oncology, growing availability of targeted and immunotherapy treatments, and advancements in biomarker-driven diagnostics. Healthcare systems worldwide are increasingly focusing on early detection,...